PharmExec

JP Morgan 2026: Eli Lilly’s Continuing GLP-1 Success

Eli Lilly came to the 44 th annual JP Morgan Healthcare Conference bolstered by a strong year. 1 While the looming patent cliff still impacts that company’s upcoming strategy, Lilly found itself in a ...

US, European Regulators Set Principles for 'Good AI Practice' in Drug Development

"The guiding principles of ​good AI practice in drug development are a first step of a renewed EU-US cooperation... to ...
Drug Target Review

Schrödinger partners with Lilly TuneLab on AI drug discovery

Learn how AI drug discovery is revolutionising pharmaceutical research through collaboration with Eli Lilly and Schrödinger.

Chai Discovery Announces Collaboration with Eli Lilly and Company to Accelerate Biologics Discovery

Chai Discovery, the AI company building a computer-aided design suite for molecules, announces Eli Lilly and Company ...

Eli Lilly’s stark new ad takes aim at public judgment around obesity

At CES, CTV marketers started to see real benefits of AI, from automated media planning to more personalized ad content.